Zhan Zhiqiang, Mei Jiaqi, Zhou Xiangwu, Jiang Sicong, Li Daojing, Wang Xuefeng
Department of Oncology, Jiangxi Pingxiang People's Hospital, Pingxiang, China.
The first clinical medical college of Nanchang University, Nanchang, China.
Front Oncol. 2022 Dec 6;12:1085305. doi: 10.3389/fonc.2022.1085305. eCollection 2022.
To explore the changes and significance of the expression level and nutritional status of human insulin-like growth factor binding protein-2 (IGFBP2) after the treatment of esophageal cancer with left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles.
A total of 110 patients with esophageal cancer (observation group: left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles) and 100 healthy people (control group) were enrolled at the same period. Then enzyme-linked immunosorbent assay (ELISA) was carried out to detect level of IGFBP-2. Lymphocyte count and serum albumin were measured by immune analyzer and automatic protein analyzer to evaluate nutritional status. Logistic regression analysis was used to analyze the relationship between serum IGFBP-2, nutritional status and prognosis of esophageal cancer after combined treatment.
The albumin, lymphocyte absolute value and PNI detection value of the control group were lower than those of the observation group 1 month after treatment, and the difference was statistically significant compared with the control group. The detection value of IGFBP-2 in early patients before and after treatment was lower than that in middle and late patients, and the detection values of albumin, lymphocyte absolute value and PNI were higher than those in middle and late patients, the differences were statistically significant. Serum IGFBP-2 level was negatively correlated with PNI, and albumin and lymphocyte absolute value were positively correlated with PNI. The detection value of IGFBP-2 in patients with good prognosis was significantly lower than that in patients with poor prognosis, and the detection values of albumin, lymphocyte absolute value and PNI were significantly higher than those in patients with poor prognosis. The AUC (0.887,95% CI: 0.799-0.975) of IGFBP-2, albumin, lymphocyte absolute value and PNI in predicting poor prognosis of esophageal cancer was the largest, and the sensitivity and specificity were 94.12% and 92.47%, respectively.
Left neck anastomosis combined with ^(125)I particle application nutritional tube is helpful for the decrease of serum IGFBP-2 and the increase of various nutritional status indicators, which is beneficial for the improvement of the patient's condition.
探讨左颈吻合术联合置入载有^(125)I粒子的营养饲管治疗食管癌后人类胰岛素样生长因子结合蛋白2(IGFBP2)表达水平及营养状况的变化及意义。
同期纳入110例食管癌患者(观察组:左颈吻合术联合置入载有^(125)I粒子的营养饲管)和100例健康人(对照组)。然后采用酶联免疫吸附测定(ELISA)法检测IGFBP - 2水平。采用免疫分析仪和自动蛋白分析仪检测淋巴细胞计数和血清白蛋白以评估营养状况。采用Logistic回归分析联合治疗后血清IGFBP - 2、营养状况与食管癌预后的关系。
治疗1个月后,对照组白蛋白、淋巴细胞绝对值及PNI检测值低于观察组,与对照组比较差异有统计学意义。早期患者治疗前后IGFBP - 2检测值低于中晚期患者,白蛋白、淋巴细胞绝对值及PNI检测值高于中晚期患者,差异有统计学意义。血清IGFBP - 2水平与PNI呈负相关,白蛋白和淋巴细胞绝对值与PNI呈正相关。预后良好患者的IGFBP - 2检测值显著低于预后不良患者,白蛋白、淋巴细胞绝对值及PNI检测值显著高于预后不良患者。IGFBP - 2、白蛋白、淋巴细胞绝对值及PNI预测食管癌预后不良的AUC(0.887,95%CI:0.799 - 0.975)最大,灵敏度和特异度分别为94.12%和92.47%。
左颈吻合术联合^(125)I粒子应用营养管有助于降低血清IGFBP - 2水平,提高各项营养状况指标,有利于改善患者病情。